Skip to main content
Top
Published in: BMC Cancer 1/2016

Open Access 01-12-2016 | Erratum

Erratum to: Conformational changes and translocation of tissue-transglutaminase to the plasma membranes: role in cancer cell migration

Authors: Ambrish Kumar, Jianjun Hu, Holly A. LaVoie, Kenneth B. Walsh, Donald J. DiPette, Ugra S. Singh

Published in: BMC Cancer | Issue 1/2016

Login to get access

Excerpt

Unfortunately, the original version of this article [1] contained an error in Fig. 1. In Fig. 1A the images in column 2 row 1, column 3 row 1 and column 1 row 6 are duplicated in column 1 row 5, column 3 row 5 and column 3 row 6, respectively. This duplication does not affect the results, findings, interpretation, conclusions, or the scientific basis of the article. The graph and statistical analysis related to the photomicrograph in Fig. 1A are correct and taken from the correct images. The correct version of Fig. 1 is below.
Metadata
Title
Erratum to: Conformational changes and translocation of tissue-transglutaminase to the plasma membranes: role in cancer cell migration
Authors
Ambrish Kumar
Jianjun Hu
Holly A. LaVoie
Kenneth B. Walsh
Donald J. DiPette
Ugra S. Singh
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2016
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-016-2567-8

Other articles of this Issue 1/2016

BMC Cancer 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine